Cost–utility and cost-effectiveness of physical exercise during adjuvant chemotherapy

Waart, Hanna van; Dongen, Johanna M. van; Harten, Wim H. van; Stuiver, Martijn M.; Huijsmans, Rosalie J.; Vreeswijk, Jeannette A. J. H. H. Hellendoorn-van; Sonke, Gabe S.; Aaronson, Neil K.

doi:10.1007/s10198-017-0936-0

Cited by 44 publications

(69 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A comparison of OncoMove and OnTrack found that OncoMove was unlikely to be cost‐effective apart from very high willingness‐to‐pay thresholds. OnTrack, in contrast, had an incremental cost‐effectiveness ratio compared with usual care of €26,916 per quality‐adjusted life‐year, which falls within some endorsed willingness‐to‐pay thresholds …”

Section: Implementation Issuesmentioning

confidence: 82%

“…Center‐based, clinician‐supervised programs are notably more expensive. For example, OncoMove, a home‐based, self‐managed exercise program, costs $53 per patient, whereas OnTrack, a physical therapist‐supervised, facility‐based exercise program, costs $866 per patient . Both programs extend from the first chemotherapy visit to 3 weeks after the last chemotherapy visit.…”

Section: Implementation Issuesmentioning

confidence: 99%

“…It is as yet unclear whether such programs are more cost‐effective compared with monodimensional programs . The association of greater value with more resource‐intensive programs complicates the challenge facing provider organizations seeking to offer programming that will benefit their patients …”

Section: Implementation Issuesmentioning

confidence: 99%

“…OnTrack, in contrast, had an incremental costeffectiveness ratio compared with usual care of €26,916 per quality-adjusted life-year, which falls within some endorsed willingness-to-pay thresholds. 85 In addition, reports suggest that analyses including comprehensive costs, which capture reductions in health care utilization more consistently, favor resource-intensive and exercise-intensive programs. A randomized trial that compared high-intensity and low-intensity exercise programs found that the former were cost-effective, mostly due to significantly lower health care costs in the high-intensity exercise group.…”

Section: Cost and Compensationmentioning

confidence: 99%

See 3 more Smart Citations

Exercise is medicine in oncology: Engaging clinicians to help patients move through cancer

Schmitz

Campbell

Stuiver

et al. 2019

CA A Cancer J Clinicians

Self Cite

455

408

View full text Add to dashboard Cite

Multiple organizations around the world have issued evidence‐based exercise guidance for patients with cancer and cancer survivors. Recently, the American College of Sports Medicine has updated its exercise guidance for cancer prevention as well as for the prevention and treatment of a variety of cancer health‐related outcomes (eg, fatigue, anxiety, depression, function, and quality of life). Despite these guidelines, the majority of people living with and beyond cancer are not regularly physically active. Among the reasons for this is a lack of clarity on the part of those who work in oncology clinical settings of their role in assessing, advising, and referring patients to exercise. The authors propose using the American College of Sports Medicine's Exercise Is Medicine initiative to address this practice gap. The simple proposal is for clinicians to assess, advise, and refer patients to either home‐based or community‐based exercise or for further evaluation and intervention in outpatient rehabilitation. To do this will require care coordination with appropriate professionals as well as change in the behaviors of clinicians, patients, and those who deliver the rehabilitation and exercise programming. Behavior change is one of many challenges to enacting the proposed practice changes. Other implementation challenges include capacity for triage and referral, the need for a program registry, costs and compensation, and workforce development. In conclusion, there is a call to action for key stakeholders to create the infrastructure and cultural adaptations needed so that all people living with and beyond cancer can be as active as is possible for them.

show abstract

Section: Implementation Issuesmentioning

confidence: 82%

Section: Implementation Issuesmentioning

confidence: 99%

Section: Implementation Issuesmentioning

confidence: 99%

Section: Cost and Compensationmentioning

confidence: 99%

See 2 more Smart Citations

Exercise is medicine in oncology: Engaging clinicians to help patients move through cancer

Schmitz

Campbell

Stuiver

et al. 2019

CA A Cancer J Clinicians

Self Cite

455

408

View full text Add to dashboard Cite

show abstract

“…It is also interesting that treatment rates for remediable physical impairments in cancer rehabilitation are lower than 2% [57]. There are still too few cost-benefit analyzes for the implementation and conversion of rehabilitation programs [58]. However, physical activity can and should be integrated into regular routine care and should be adapted to individual circumstances among breast cancer survivors [59].…”

Section: Discussionmentioning

confidence: 99%

Physical Activity, Exercise and Breast Cancer - What Is the Evidence for Rehabilitation, Aftercare, and Survival A Review

Wirtz

Baumann

2018

Breast Care

View full text Add to dashboard Cite

The current scientific field of exercise interventions in breast cancer is very large. Rehabilitation focuses on restoring or improving quality of life and thus on independence and participation in life. Hence, it is important to investigate exercise interventions in the setting of rehabilitation and aftercare. It is also necessary to determine the influence of physical activity or exercise therapy on the prevention of recurrence and mortality as well as on certain side effects of the disease and its medical treatment in rehabilitation. Physical activity in rehabilitation and aftercare is feasible and safe and can be used for various purposes. Against the background of reduced fatigue, chemotherapy-induced peripheral neuropathy, cancer-related cognitive impairment, arthralgia, lymphedema, recurrence, and mortality, as well as improved quality of life, different methodological approaches and evidence can be seen. Although the overall data availability has increased, there are gaps in study documentation as well as inadequate verification of scientific approaches in rehabilitation clinics and in everyday life.

show abstract

Non-medical interventions to enhance return to work for people with cancer

de Boer,

Tamminga,

Boschman

et al. 2024

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Cost–utility and cost-effectiveness of physical exercise during adjuvant chemotherapy

Abstract: Onco-Move is not likely to be cost-effective. Depending on the decision-makers' willingness-to-pay, OnTrack could be considered cost-effective in comparison with UC. Trial registration Clinical trial registration number of the Netherlands Trial Register-NTR2159.

Cited by 44 publications

References 26 publications

Exercise is medicine in oncology: Engaging clinicians to help patients move through cancer

Exercise is medicine in oncology: Engaging clinicians to help patients move through cancer

Physical Activity, Exercise and Breast Cancer - What Is the Evidence for Rehabilitation, Aftercare, and Survival A Review

Non-medical interventions to enhance return to work for people with cancer

Contact Info

Product

Resources

About